Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
2019 · Neuropsychopharmacology · 50 citations
https://doi.org/10.1038/s41386-019-0365-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
337
Citations
5
h-index
4
i10-index
Andrew Glasgow is an academic researcher. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Anesthesia and Neurotoxicity Research. The author has an h-index of 5, co-authored 8 publications.
ORCID: 0000-0001-8928-1934https://doi.org/10.1038/s41386-019-0365-0
https://doi.org/10.1016/j.hpb.2021.06.007
Click to start Chat